Catheter Precision has announced a major expansion in its business development team. The company is bolstering its sales team with experienced industry veterans to drive growth and market penetration. David Jenkins, Catheter Precision’s CEO, commented on the expansion efforts. “This is a group that I have known for almost twenty years. They are top performers from a company which was acquired by a large medical device company a couple years ago. This group led their prior company, with its unique electrophysiology products, to reach over $100 million of sales and then its acquisition for $1.7 billion. I am confident that their efforts will be repeated here at Catheter Precision.” The new expansion of these veteran sales persons includes five hired on and trained in the first quarter, two more slated to start next week, and one more toward the end of April. In addition to these hires, during the first quarter, the company also brought on technical expertise with Madison Spence, most recently from Acutus, and David Pollmeier in Europe, most recently from Galaxy Medical.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VTAK:
- Catheter Precision Q4 revenue $128,800 vs. $0 last year
- Catheter Precision to sponsor Monaco USA Arrhythmia Course
- Catheter Precision announces first use of VIVO in Qatar
- Catheter Precision announces first use of LockeT outside of U.S.
- Catheter Precision announces first use of VIVO with pediatric patient